Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts
<p>A strong positive association has been observed between circulating anti-Müllerian hormone (AMH), a biomarker of ovarian reserve, and breast cancer risk in three prospective studies. Confirming this association is important because of the paucity of biomarkers of breast cancer risk in preme...
Main Authors: | Ge, W, Clendenen, TV, Afanasyeva, Y, Koenig, KL, Agnoli, C, Brinton, LA, Dorgan, JF, Eliassen, AH, Falk, RT, Hallmans, G, Hankinson, SE, Hoffman-Bolton, J, Key, TJ, Krogh, V, Nichols, HB, Sandler, DP, Schoemaker, MJ, Sluss, PM, Sund, M, Swerdlow, AJ, Visvanathan, K, Liu, M, Zeleniuch-Jacquotte, A |
---|---|
Format: | Journal article |
Izdano: |
Wiley
2018
|
Podobne knjige/članki
-
Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts
od: Jung, S, et al.
Izdano: (2017) -
Anti-Mullerian hormone and endometrial cancer: a multi-cohort study
od: Fortner, RT, et al.
Izdano: (2017) -
Mechanistic drivers of Müllerian duct development and differentiation into the oviduct
od: Santana Gonzalez, L, et al.
Izdano: (2021) -
Emerging roles of anti-Müllerian hormone in hypothalamic-pituitary function
od: Barbotin, A, et al.
Izdano: (2019) -
Studying Müllerian duct anomalies - from cataloguing phenotypes to discovering causation
od: Santana González, L, et al.
Izdano: (2021)